Login to Your Account

Extending the Runway: $54M Cash Infusion for Symphogen

By Nuala Moran
Staff Writer

Wednesday, May 8, 2013
LONDON – Symphogen A/S has taken in a further €41 million (US$54.1 million) as an extension to an earlier €100 million round agreed in 2011, bringing the total raised to $185 million.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription